HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ASA: YSL’s Black Opium Fragrance Ads Do Not ‘Glamorize’ Drug Use

This article was originally published in The Rose Sheet

Executive Summary

U.K. advertising watchdog group agrees with L’Oreal and its Yves Saint Laurent division that ads for Black Opium fragrance do not simulate drug use or trivialize addiction, but instead tell the story of a woman who is relieved to track down and be reunited with an important piece of her identity – her perfume.

You may also be interested in...



Marketing Misfires? YSL’s Black Opium; Pinrose’s Witch Kit; Becca’s ‘Blackface’ Bungle

Whether they reflect marketing failures or simply the powder keg that is today’s digital marketing environment, recent backlashes against cosmetics brands show how online exposure can be a double-edged sword.

US Rep. Schakowsky Wants Cosmetic Supply Chain Transparency; Benzene In Sunscreen Cited

Cosmetic ingredient and raw material suppliers would be required to share toxicity and safety data with brand owners, along with certificates of analysis and contaminant testing reports, under the Cosmetic Supply Chain Transparency Act of 2021. The bill is part of a proposed Safer Beauty package introduced in the US House on 29 July by Jan Schakowsky, D-IL, and colleagues.

Hard To Kill: Class Actions Drag On Against Sanitizer Lethality Claims

Plaintiffs are down, but not out, with allegations of false advertising against hand sanitizer manufacturers using 99.99% germ-killing claims.

UsernamePublicRestriction

Register

RS019665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel